CLEC1B(C-type lectin domain family 1 member B)属于C型凝集素家族(CLEC家族),是一类重要的免疫相关基因家族,其成员通常编码含有C型凝集素结构域的蛋白质,参与病原体识别、免疫调节和细胞间相互作用。CLEC1B编码的蛋白主要表达于血小板和树突状细胞,通过与配体结合参与凝血和免疫应答。其生物学功能包括促进血小板聚集和血栓形成,并在炎症反应中发挥作用。CLEC1B的配体包括某些病原体相关分子模式(PAMPs)和损伤相关分子模式(DAMPs),通过识别这些分子激活下游信号通路。突变或异常表达可能影响血小板功能,导致出血倾向或血栓性疾病。研究表明,CLEC1B与深静脉血栓形成(DVT)和某些自身免疫性疾病相关。过表达可能增加血栓风险,而降低表达可能导致止血功能障碍。CLEC1B与同家族成员(如CLEC1A、CLEC2)具有相似的结构和功能特征,均参与免疫识别和细胞信号传导。该基因家族在先天免疫和适应性免疫中发挥关键作用,通过识别糖基化模式调控免疫细胞活性。
Natural killer (NK) cells express multiple calcium-dependent (C-type) lectin-like receptors, such as CD94 (KLRD1; MIM 602894) and NKG2D (KLRC4; MIM 602893), that interact with major histocompatibility complex class I molecules and either inhibit or activate cytotoxicity and cytokine secretion. CLEC2 is a C-type lectin-like receptor expressed in myeloid cells and NK cells (Colonna et al., 2000 [PubMed 10671229]).[supplied by OMIM, Jan 2011]
Subcellular localization of CLEC1B (and its protein):
Gene Ontology (GO) terms for CLEC1B:
| Interacting Gene | Interaction | Source/Score |
| Disease | Score | NofPmids | NofSnps | Source |
| Neoplasm Metastasis | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Rheumatoid Arthritis | 0.002638474 | 2 | 0 | BeFree_GAD |
| Coronary Artery Disease | 0.002367032 | 1 | 0 | GAD |
| Diabetes Mellitus, Insulin-Dependent | 0.002367032 | 1 | 0 | GAD |
| Hypertensive disease | 0.002367032 | 1 | 0 | GAD |
| Diabetes Mellitus, Non-Insulin-Dependent | 0.002367032 | 1 | 0 | GAD |
| Crohn Disease | 0.002367032 | 1 | 0 | GAD |
| Albuminuria | 0.002367032 | 1 | 1 | GAD |
| Blood Coagulation Disorders | 0.000271442 | 1 | 0 | BeFree |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com